Perspective Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright initiated coverage of Perspective Therapeutics (CATX) with a Buy rating and $10 price target Perspective is a clinical-stage ...
HC Wainwright Has Bearish Estimate for ONCY FY2029 Earnings
Stock analysts at HC Wainwright reduced their FY2029 earnings estimates for Oncolytics Biotech in a research note issued on ...
AudioEye price target lowered to $22 from $37 at H.C. Wainwright
H.C. Wainwright analyst Scott Buck lowered the firm’s price target on AudioEye (AEYE) to $22 from $37 and keeps a Buy rating on the shares post ...
Stocktwits on MSN1d
Core Scientific Stock Gains As HC Wainwright Reiterates Rating On CoreWeave's $12B OpenAI Deal: Retail Stays Extremely Bullish
Shares of Core Scientific Inc. (CORZ) gained almost 8% in Tuesday’s regular session and extended gains during after-hours ...
CoinDesk2d
U.S. Strategic Bitcoin Reserve a 'Monumental Endorsement' of the Crypto: H.C. Wainwright
The establishment of a Strategic Bitcoin Reserve (SBR) in the U.S. is a "monumental endorsement" of the world's largest ...
FY2028 Earnings Estimate for TSE:ONC Issued By HC Wainwright
Investment analysts at HC Wainwright cut their FY2028 earnings per share (EPS) estimates for Oncolytics Biotech in a research ...
Fintel on MSN2d
HC Wainwright & Co. Initiates Coverage of Inuvo (INUV) with Buy Recommendation
Fintel reports that on March 11, 2025, HC Wainwright & Co. initiated coverage of Inuvo (NYSEAM:INUV) with a Buy ...
H.C. Wainwright says Novo results support Viking obesity potential
REDEFINE-2 results reinforce Viking Therapeutics’ (VKTX) VK2735’s potential in obesity and beyond. Assuming full adherence, Novo’s CagriSema achieved 15.7% weight loss compared to 3.1% with placebo, ...
Cantargia to Participate at H.C. Wainwright’s Annual Autoimmune & Inflammatory Virtual Conference
Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm: CANTA) today announced that Damian Marron, Interim CEO, will participate ...
Nasdaq9d
HC Wainwright & Co. Initiates Coverage of Surf Air Mobility (SRFM) with Buy Recommendation
Fintel reports that on March 7, 2025, HC Wainwright & Co. initiated coverage of Surf Air Mobility (NYSE:SRFM) with a Buy recommendation. As of March 4, 2025, the average one-year price target for ...
Nasdaq8d
HC Wainwright & Co. Initiates Coverage of Intellia Therapeutics (LSE:0JBU) with Buy Recommendation
Fintel reports that on March 5, 2025, HC Wainwright & Co. initiated coverage of Intellia Therapeutics (LSE:0JBU) with a Buy recommendation. There are 572 funds or institutions reporting positions ...
Is Surf Air Mobility Flying Under The Investor Radar? Analyst Weighs In
H.C. Wainwright analyst Amit Dayal initiated coverage on Surf Air Mobility Inc. (NYSE:SRFM) with a Buy rating and price forecast of $12. The analyst writes that the company is positioned for a ...